The benefit of late readings in patch testing depends both on allergen and patient characteristics.

allergic contact dermatitis day 7 reading late patch test reaction reaction pattern sodium lauryl sulfate

Journal

Allergy
ISSN: 1398-9995
Titre abrégé: Allergy
Pays: Denmark
ID NLM: 7804028

Informations de publication

Date de publication:
05 2022
Historique:
received: 09 06 2021
accepted: 09 10 2021
pubmed: 24 10 2021
medline: 3 5 2022
entrez: 23 10 2021
Statut: ppublish

Résumé

Patch test (PT) readings are recommended after 48 h and 72 h (D3). An additional day 7 (D7) reading has been suggested by some, although data on efficient patient selection are scarce. We investigated positive D7 reactions regarding (i) allergens in the baseline series and additional PT series of the German Contact Dermatitis Research Group (DKG) and (ii) characteristics of the patients tested. Retrospective, multicentre analysis of 190 allergens derived from 17 DKG test series in 4687 patients with an additional D7 reading. Patients were patch tested with the baseline series and additional series, if required. Occurrence of novel D7 reactions as well as increasing skin reactions from D3 to D7 was analysed separately. Depending on the allergen tested, waiving D7 readings would have missed 4.4-26.8% of positive PT results. Patch test series with the highest number of novel D7 reactions were baseline series, metal series, and leather/shoe series. New positive reactions on D7 were associated with age over 50 years and with a negative irritant control containing sodium lauryl sulphate. Of note, application of the PT allergens for 48 h instead of 24 h was positively associated with late PT reactions. Within the most frequently tested allergens, without late readings, on average 11.7% of sensitizations would have been missed. Novel late reacting allergens were identified. This study comprehensively dissects patient-, allergen- and test-dependent parameters in support for D7 readings. We propose to always consider late readings individually based on effort-benefit considerations.

Sections du résumé

BACKGROUND
Patch test (PT) readings are recommended after 48 h and 72 h (D3). An additional day 7 (D7) reading has been suggested by some, although data on efficient patient selection are scarce. We investigated positive D7 reactions regarding (i) allergens in the baseline series and additional PT series of the German Contact Dermatitis Research Group (DKG) and (ii) characteristics of the patients tested.
METHODS
Retrospective, multicentre analysis of 190 allergens derived from 17 DKG test series in 4687 patients with an additional D7 reading. Patients were patch tested with the baseline series and additional series, if required. Occurrence of novel D7 reactions as well as increasing skin reactions from D3 to D7 was analysed separately.
RESULTS
Depending on the allergen tested, waiving D7 readings would have missed 4.4-26.8% of positive PT results. Patch test series with the highest number of novel D7 reactions were baseline series, metal series, and leather/shoe series. New positive reactions on D7 were associated with age over 50 years and with a negative irritant control containing sodium lauryl sulphate. Of note, application of the PT allergens for 48 h instead of 24 h was positively associated with late PT reactions.
CONCLUSION
Within the most frequently tested allergens, without late readings, on average 11.7% of sensitizations would have been missed. Novel late reacting allergens were identified. This study comprehensively dissects patient-, allergen- and test-dependent parameters in support for D7 readings. We propose to always consider late readings individually based on effort-benefit considerations.

Identifiants

pubmed: 34687560
doi: 10.1111/all.15149
doi:

Substances chimiques

Allergens 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1477-1485

Informations de copyright

© 2021 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.

Références

Mahler V, Nast A, Bauer A, et al. S3 guidelines: Epicutaneous patch testing with contact allergens and drugs - short version, Part 1. J Dtsch Dermatol Ges. 2019;17(10):1076-1093.
Mahler V, Nast A, Bauer A, et al. S3 Guidelines: Epicutaneous patch testing with contact allergens and drugs - short version, Part 2. J Dtsch Dermatol Ges. 2019;17(11):1187-1207.
Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis. 2015;73(4):195-221.
van Amerongen CCA, Ofenloch R, Dittmar D, Schuttelaar MLA. New positive patch test reactions on day 7-The additional value of the day 7 patch test reading. Contact Dermatitis. 2019;81(4):280-287.
Dickel H, Taylor JS, Evey P, Merk HF. Delayed readings of a standard screening patch test tray: frequency of "lost," "found," and "persistent" reactions. Am J Contact Dermat. 2000;11(4):213-217.
Yüksel YT, Sedeh FB, Brans R, et al. Value of photo assessment in late patch test readings-A multicenter study from six European patch test clinics. Contact Dermatitis. 2021;84(5):283-289.
Schnuch A, Geier J, Lessmann H, Arnold R, Uter W. Surveillance of contact allergies: methods and results of the Information Network of Departments of Dermatology (IVDK). Allergy. 2012;67(7):847-857.
Uter W, Schnuch A, Gefeller O. Guidelines for the descriptive presentation and statistical analysis of contact allergy data. Contact Dermatitis. 2004;51(2):47-56.
Löffler H, Becker D, Brasch J, Geier J. Simultaneous sodium lauryl sulphate testing improves the diagnostic validity of allergic patch tests. Results from a prospective multicentre study of the German Contact Dermatitis Research Group (Deutsche Kontaktallergie-Gruppe, DKG). Br J Dermatol. 2005;152(4):709-719.
Cantwell HM, Drage LA, El-Azhary RA, et al. The final patch test read: day 5 or day >7? Dermatitis. 2020;31(1):42-52.
Jonker MJ, Bruynzeel DP. The outcome of an additional patch-test reading on days 6 or 7. Contact Dermatitis. 2000;42(6):330-335.
Macfarlane AW, Curley RK, Graham RM, Lewis-Jones MS, King CM. Delayed patch test reactions at days 7 and 9. Contact Dermatitis. 1989;20(2):127-132.
Geier J, Gefeller O, Wiechmann K, Fuchs T. Patch test reactions at D4, D5 and D6. Contact Dermatitis. 1999;40(3):119-126.
Chaudhry HM, Drage LA, El-Azhary RA, et al. Delayed patch-test reading after 5 days: an update from the mayo clinic contact dermatitis group. Dermatitis. 2017;28(4):253-260.
Bruze M, Hedman H, Björkner B, Möller H. The development and course of test reactions to gold sodium thiosulfate. Contact Dermatitis. 1995;33(6):386-391.
Ahlström MG, Thyssen JP, Wennervaldt M, Menné T, Johansen JD. Nickel allergy and allergic contact dermatitis: a clinical review of immunology, epidemiology, exposure, and treatment. Contact Dermatitis. 2019;81(4):227-241.
Hamann D, Bruze M, Fowler JF, et al. Excipient and dose per unit area affect sensitivity when patch testing with gold sodium thiosulfate. Dermatitis. 2018;29(5):258-263.
Andersen KE, Jensen CD. Long-lasting patch reactions to gold sodium thiosulfate occurs frequently in healthy volunteers. Contact Dermatitis. 2007;56(4):214-217.
Madsen JT, Andersen KE. Outcome of a second patch test reading of TRUE Tests® on D6/7. Contact Dermatitis. 2013;68(2):94-97.
Zimerson E, Bruze M. Demonstration of the contact sensitizer p-tert-butylcatechol in p-tert-butylphenol formaldehyde resin. Am J Contact Dermat. 1999;10(1):2-6.
Hillen U, Jappe U, Frosch PJ, et al. Late reactions to the patch-test preparations para-phenylenediamine and epoxy resin: a prospective multicentre investigation of the German Contact Dermatitis Research Group. Br J Dermatol. 2006;154(4):665-670.
Hillen U, Frosch PJ, John SM, et al. Patch test sensitization caused by para-tertiary-butylcatechol. Results of a prospective study with a dilution series. Contact Dermatitis. 2001;45(4):193-196.
Hillen U, Dickel H, Löffler H, et al. Late reactions to patch test preparations with reduced concentrations of p-phenylenediamine: a multicentre investigation of the German Contact Dermatitis Research Group. Contact Dermatitis. 2011;64(4):196-202.
Dhingra N, Shemer A, Correa da Rosa J, et al. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 2014;134(2):362-372.
Claßen A, Buhl T, Schubert S, et al. The frequency of specific contact allergies is reduced in patients with psoriasis. Br J Dermatol. 2019;180(2):315-320.
Pendlington RU, Minter HJ, Stupart L, et al. Development of a modified in vitro skin absorption method to study the epidermal/dermal disposition of a contact allergen in human skin. Cutan Ocul Toxicol. 2008;27(4):283-294.
Prakash AV, Davis MD. Contact dermatitis in older adults: a review of the literature. Am J Clin Dermatol. 2010;11(6):373-381.
Lima AL, Timmermann V, Illing T, Elsner P. Contact dermatitis in the elderly: predisposing factors, diagnosis, and management. Drugs Aging. 2019;36(5):411-417.
Garg S, McDonagh AJ, Gawkrodger DJ. Age- and sex-related variations in allergic contact dermatitis to common allergens. Contact Dermatitis. 2009;61(1):46-47.
Kwangsukstith C, Maibach HI. Effect of age and sex on the induction and elicitation of allergic contact dermatitis. Contact Dermatitis. 1995;33(5):289-298.
Heetfeld AB, Schill T, Schröder SS, et al. Challenging a paradigm: skin sensitivity to sodium lauryl sulfate is independent of atopic diathesis. Br J Dermatol. 2020;183(1):139-145.
Forkel S, Cevik N, Schill T, et al. Atopic skin diathesis rather than atopic dermatitis is associated with specific contact allergies. J Dtsch Dermatol Ges. 2021;19(2):231-240.
Schwitulla J, Brasch J, Löffler H, et al. Skin irritability to sodium lauryl sulfate is associated with increased positive patch test reactions. Br J Dermatol. 2014;171(1):115-123.
Raffi J, Suresh R, Botto N, Murase JE. The impact of dupilumab on patch testing and the prevalence of comorbid allergic contact dermatitis in recalcitrant atopic dermatitis: a retrospective chart review. J Am Acad Dermatol. 2020;82(1):132-138.
Wee JS, White JM, McFadden JP, White IR. Patch testing in patients treated with systemic immunosuppression and cytokine inhibitors. Contact Dermatitis. 2010;62(3):165-169.
Higgins EM, McLelland J, Friedmann PS, Matthews JN, Shuster S. Oral cyclosporin inhibits the expression of contact hypersensitivity in man. J Dermatol Sci. 1991;2(2):79-83.
Kalimo K, Lammintausta K. 24 and 48 h allergen exposure in patch testing. Comparative study with 11 common contact allergens and NiCl2. Contact Dermatitis. 1984;10(1):25-29.
Brasch J, Geier J, Henseler T. Evaluation of patch test results by use of the reaction index. An analysis of data recorded by the Information Network of Departments of Dermatology (IVDK). Contact Dermatitis. 1995;33(6):375-380.
Goh CL, Wong WK, Ng SK. Comparison between 1-day and 2-day occlusion times in patch testing. Contact Dermatitis. 1994;31(1):48-50.
Ale SI, Maibach HI. 24-hour versus 48-hour occlusion in patch testing. Exogenous Dermatology. 2003;2(5):270-276.
Aalto-Korte K, Suomela S, Pesonen M. Allergic reactions to lower concentrations of nickel sulfate and formaldehyde often appear later than reactions to higher concentrations. Contact Dermatitis. 2019;80(3):162-165.
Young E, Andersen KE, Bruze M, et al. Twenty-eight-day follow-up of patch test reactions to p-phenylenediamine and p-phenylenediamine dihydrochloride: a multicentre study on behalf of the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis. 2019;81(1):1-8.

Auteurs

Susann Forkel (S)

Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.

Steffen Schubert (S)

Information Network of Departments of Dermatology, Institute at the University Medical Center Göttingen, Göttingen, Germany.

Heinrich Dickel (H)

Department of Dermatology, Venereology and Allergology, St. Josef Hospital, University Medical Center of the Ruhr University Bochum (UK RUB), Bochum, Germany.

Michal Gina (M)

Department of Occupational Dermatology, BG Hospital Falkenstein, Falkenstein, Germany.

Claudia Schröder-Kraft (C)

Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm), BG Hospital Hamburg, Hamburg, Germany.

Dieter Vieluf (D)

Department of Allergology, Photodermatology and Occupational Dermatology, Dermatologikum Hamburg, Hamburg, Germany.

Richard Brans (R)

Institute for Interdisciplinary Dermatological Prevention and Rehabilitation (iDerm) at the University of Osnabrück, Osnabrück, Germany.
Department of Dermatology, Environmental Medicine and Health Theory, University of Osnabrück, Osnabrück, Germany.
Lower Saxony Institute of Occupational Dermatology, University of Osnabrück, Osnabrück, Germany.

Burkhard Kreft (B)

Department of Dermatology, Venereology and Allergology, University Medical Center Halle, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Gerda Wurpts (G)

Department of Dermatology, Venereology and Allergology, University Medical Center Aachen, Aachen, Germany.

Johannes Geier (J)

Information Network of Departments of Dermatology, Institute at the University Medical Center Göttingen, Göttingen, Germany.
Lower Saxony Institute of Occupational Dermatology, University of Göttingen, Göttingen, Germany.

Timo Buhl (T)

Department of Dermatology, Venereology and Allergology, University Medical Center Göttingen, Göttingen, Germany.
Lower Saxony Institute of Occupational Dermatology, University of Göttingen, Göttingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH